Gambia vs Iran: HIV-positive TB patients on ART (antiretroviral therapy)
Gambia
93.0%
in 2024
Iran
93.0%
in 2024
Gambia rank
85th
Iran rank
85th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Gambia
- Iran
How they compare
Gambia currently reports 93.0% against 93.0% in Iran, a difference of 0.0%.
The two have swapped places 7 times across 18 shared years of data; in 2006 it was Gambia ahead.
Gambia ranks 85th and Iran ranks 85th of 144 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Iran in 2.
Head to head by decade
| Decade | Gambia | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.6% | 13.5% | 0.9% | Iran |
| 2010s | 54.1% | 54.0% | 0.1% | Gambia |
| 2020s | 91.4% | 94.0% | 2.6% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Gambia or Iran?
- Gambia, at 93.0% against 93.0% in Iran as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Gambia and Iran?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Iran?
- 18 years are reported by both, from 2006 to 2024.
- How do Gambia and Iran rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Gambia ranks 85th and Iran ranks 85th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.